The Case Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1826-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.case.edu/cancer
GM-CSF in Treating Patients With Relapsed Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Biological: sargramostim
- First Posted Date
- 2009-05-25
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00908141
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507
- Conditions
- Lung Cancer
- First Posted Date
- 2009-05-22
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT00907699
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
- Conditions
- Psychosocial Effects of Cancer and Its TreatmentCognitive/Functional EffectsLung CancerProstate CancerBreast CancerColorectal Cancer
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT00905086
- Locations
- 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Lapatinib Resistance in Patients With Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT00898573
- Locations
- 🇺🇸
Geauga Regional Hospital, Cleveland, Ohio, United States
🇺🇸Lake/University Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸University Suburban Health Center, Cleveland, Ohio, United States
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
- Conditions
- Non-melanomatous Skin CancerTesticular Germ Cell TumorPancreatic CancerSmall Intestine Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2015-09-29
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 180
- Registration Number
- NCT00899132
- Locations
- 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT00900133
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss
- Conditions
- CachexiaPancreatic Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT00899158
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
- Conditions
- Metastatic CancerLung Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT00897143
- Locations
- 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
- Conditions
- Precancerous ConditionProstate Cancer
- Interventions
- Other: immunoenzyme techniqueOther: laboratory biomarker analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT00898274
- Locations
- 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸University Suburban Health Center, Cleveland, Ohio, United States
🇺🇸UHHS Chagrin Highlands Medical Center, Cleveland, Ohio, United States
Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2009-05-04
- Last Posted Date
- 2019-02-22
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 66
- Registration Number
- NCT00892385
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States